Enhanced recovery versus conventional care in gastric cancer surgery: a meta-analysis of randomized and non-randomized controlled trials Ian Jun Yan WeeNicholas Li-Xun SynJimmy B. Y. So Review Article 25 February 2019 Pages: 423 - 434
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis Kentaro Sugano Original Article 11 September 2018 Pages: 435 - 445
Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer Jessica L. MuellerDanbee H. KimJohn T. Mullen Original Article 22 August 2018 Pages: 446 - 455
How long should we continue gastric cancer screening? From an epidemiological point of view Yuri MizotaSeiichiro Yamamoto Original Article Open access 21 September 2018 Pages: 456 - 462
Near infrared photoimmunotherapy using a fiber optic diffuser for treating peritoneal gastric cancer dissemination Tadanobu NagayaShuhei OkuyamaHisataka Kobayashi Original Article 31 August 2018 Pages: 463 - 472
Functional analysis and clinical significance of sodium iodide symporter expression in gastric cancer Atsushi ShiozakiYosuke AriyoshiEigo Otsuji Original Article 06 September 2018 Pages: 473 - 485
EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions Sho SasakiJun NishikawaIsao Sakaida Original Article 28 September 2018 Pages: 486 - 496
The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells Ryutaro MoriKazuhiro YoshidaKazuya Yamaguchi Original Article Open access 01 October 2018 Pages: 497 - 505
Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China Kai LiuFan FengJian-kun Hu Original Article Open access 02 November 2018 Pages: 506 - 517
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer Shusuke YagiTakeru WakatsukiYusuke Horiuchi Original Article Open access 17 October 2018 Pages: 518 - 525
Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer Shusuke YagiTakeru WakatsukiYusuke Horiuchi Correction Open access 22 November 2018 Pages: 526 - 526
Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3) Seyoung SeoMin-Hee RyuYoon-Koo Kang Original Article 01 November 2018 Pages: 527 - 535
CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial Jun LuBin-bin XuPing Li Original Article 30 October 2018 Pages: 536 - 545
Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma Yi-Wei XuHao ChenYu-Hui Peng Original Article Open access 13 November 2018 Pages: 546 - 557
Long-term outcome of endoscopic submucosal dissection for early gastric cancer in patients with severe comorbidities: a comparative propensity score analysis Kojiro TanoueShusei FukunagaYasuhiro Fujiwara Original Article 31 October 2018 Pages: 558 - 566
The search, coagulation, and clipping (SCC) method prevents delayed bleeding after gastric endoscopic submucosal dissection Motoi AzumiManabu TakeuchiShuji Terai Original Article Open access 28 September 2018 Pages: 567 - 575
Correction to: The search, coagulation, and clipping (SCC) method prevents delayed bleeding after gastric endoscopic submucosal dissection Motoi AzumiManabu TakeuchiShuji Terai Correction Open access 23 October 2018 Pages: 576 - 576
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial Y. TouchefeuR. GuimbaudO. Bouche Original Article 11 October 2018 Pages: 577 - 586
The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study Xi ChengShan YuTian-shu Liu Original Article 13 November 2018 Pages: 587 - 597
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial Kei HosodaMizutomo AzumaKeishi Yamashita Original Article 03 October 2018 Pages: 598 - 606
Long-term quality of life and nutrition status of the aboral pouch reconstruction after total gastrectomy for gastric cancer: a prospective multicenter observational study (CCOG1505) Chie TanakaMitsuro KandaYasuhiro Kodera Original Article 31 October 2018 Pages: 607 - 616
Equivalent feasibility and safety of perioperative care by ERAS in open and laparoscopy-assisted distal gastrectomy for gastric cancer: a single-institution ancillary study using the patient cohort enrolled in the JCOG0912 phase III trial Toru AoyamaTakaki YoshikawaHaruhiko Cho Original Article 07 September 2018 Pages: 617 - 623
Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer Masashi TakeuchiHirofumi KawakuboYuko Kitagawa Original Article 26 November 2018 Pages: 624 - 631
The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancer—a randomized-controlled trial Lapo BenciniAlberto MarchetItalian Research Group for Gastric Cancer (GIRCG) Original Article 22 September 2018 Pages: 632 - 639
Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility Seon Woo LeeDo Youn ParkChangwon Kang Short Communication 29 October 2018 Pages: 640 - 644
Correction to: Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis Sivesh K. KamarajahJames BundredBenjamin H. L. Tan Correction 01 March 2019 Pages: 645 - 650
